Tenofovir disoproxil fumarate (TDF) is part of a group of antiviral HIV drugs called nucleoside reverse transcriptase inhibitors (NRTIs).
The FDA first approved it in October 2001.
The brand name drugs that contain TDF are manufactured by Gilead Sciences, Inc. and are:
- Viread®
- Atripla®
- Truvada®
- Stribild®
- Complera®
TDF-containing drugs are used as part of the treatment regimen for HIV+ positive patients.
Truvada® has also been approved for use as a Pre-Exposure Prophylactic (PrEP) by non-HIV+ individuals.
There are reports of serious side effects following TDF use, including acute and chronic kidney disease, kidney failure, loss of bone density, and broken bones.
If you have taken these drugs and experienced a listed injury, you may have a claim.
The manufacturer of the TDF drugs, Gilead Sciences Inc., allegedly sold this drug while withholding a safer alternative that was less toxic to patients.